Market Movers

Walgreens Boots Alliance, Inc.’s Stock Price Takes a Hit, Drops to $9.26 Amid 3.74% Decrease

By December 31, 2024 No Comments

Walgreens Boots Alliance, Inc. (WBA)

9.26 USD -0.36 (-3.74%) Volume: 13.83M

Walgreens Boots Alliance, Inc.’s stock price stands at 9.26 USD, experiencing a -3.74% change this trading session with a trading volume of 13.83M, reflecting a significant year-to-date percentage change of -64.53%, indicating a challenging market performance for WBA.


Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance (WBA) has been making headlines recently as investors speculate on its potential as one of the best low priced stocks to invest in now. The company has been actively working on restructuring its operations and expanding its digital offerings to stay competitive in the ever-evolving retail landscape. This has led to increased investor interest and optimism in the stock. Additionally, with the recent fluctuations in the market, many investors are keeping a close eye on WBA as a potential opportunity for growth. As a result, the stock price movements of Walgreens Boots Alliance today are closely watched by investors looking to capitalize on its potential as a low priced stock with high growth prospects.


Walgreens Boots Alliance, Inc. on Smartkarma

Analysts at Baptista Research have been closely monitoring Walgreens Boots Alliance (WBA) on Smartkarma. In one report titled “Walgreens Buyout Buzz: Why Sycamore Partners May Bet Big on the Struggling Pharmacy Giant!”, the analysts discuss potential buyout discussions with Sycamore Partners, a private equity firm. The report highlights how Walgreens’ shares surged amid these talks, amidst a challenging business environment marked by margin pressures, store closures, and rising operating costs.

In another report by Baptista Research, titled “Walgreens Boots Alliance Inc.: Capital Discipline & Store Optimization To Orchestrate A Turnaround? – Major Drivers”, the analysts delve into the company’s Fourth Quarter FY 2024 results. The report discusses strategic and operational shifts, cost-cutting measures, CapEx reduction, and improvements in working capital that contributed to a positive cash flow in the quarter. The analysts aim to evaluate factors influencing the company’s price in the near future and conduct an independent valuation using a Discounted Cash Flow methodology.


A look at Walgreens Boots Alliance, Inc. Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth2
Resilience2
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance, Inc. has received high scores in Value and Dividend, indicating a positive long-term outlook for the company in terms of its financial stability and shareholder returns. However, the scores for Growth and Resilience are lower, suggesting potential challenges in these areas. Despite this, the company has shown strong Momentum, which could help drive future growth and performance.

As a retail drugstore operator offering a wide range of health services, Walgreens Boots Alliance, Inc. has positioned itself well in the market. With high scores in Value and Dividend, the company appears to be a solid investment option for those looking for stability and income. While Growth and Resilience scores are not as strong, the company’s Momentum score indicates that it may be able to overcome any obstacles and continue on a positive trajectory in the long term.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars